SCHEMBL24089913

CCCCC[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)C(NC(=O)[C@@H](NC(=O)[C@@H](CCCCN)NC(=O)CNC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@@H](Cc1ccccc1)NC(=O)CCOCCOCCOCCOCCOCCNC(=O)CCCC[C@@H]1CC[C@H]2NC(=O)N[C@@H]12)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@H](CO)C(=O)NC(C(=O)N[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CN)C(C)C)C(C)C)[C@@H](C)O

nearest known ligand 0.46

Predicted protein targets (top 12)

	gene	UniProt	supporting neighbours	confidence
▸	GLP1R	P43220	11/20	0.46

▸	PLG	P00747	1/20	0.45

▸	PRSS1	P07477	1/20	0.45

▸	PRSS2	P07478	1/20	0.45

▸	PRSS3	P35030	1/20	0.45

▸	TPSAB1	Q15661	1/20	0.45

▸	IL23R	Q5VWK5	2/20	0.44

▸	GCGR	P47871	1/20	0.44

▸	OPRL1	P41146	2/20	0.43

▸	PCSK9	Q8NBP7	1/20	0.43

▸	SCTR	P47872	1/20	0.43

▸	RXFP1	Q9HBX9	3/20	0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL22550645	0.86	PLG (0.57)	GLP1RPLGPRSS1PRSS2PRSS3
SCHEMBL24089915	0.80	GLP1R (0.51)	GLP1RIL23RGCGRSCTR
SCHEMBL24089914	0.78	RAMP3 (0.51)	GLP1R
SCHEMBL22550672	0.77	GLP1R (0.54)	GLP1RPLGPRSS1PRSS2PRSS3
SCHEMBL22550671	0.72	RAMP3 (0.53)	GLP1RPLGPRSS1PRSS2PRSS3
SCHEMBL30880906	0.70	TFPI (0.58)	IL23ROPRL1
SCHEMBL22550646	0.69	RAMP3 (0.53)	GLP1R
SCHEMBL30313496	0.69	CASP3 (0.47)	GLP1RPLGPRSS1PRSS2PRSS3
SCHEMBL10169246	0.69	GLP1R (0.55)	GLP1RIL23RGCGROPRL1
SCHEMBL10168556	0.69	GLP1R (0.54)	GLP1RIL23RGCGROPRL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-20210380640-A1	SARS-CoV-2 EPITOPE-TARGETED PEPTIDE IMMUNOSTIMULANTS	INSTITUTE FOR SYSTEMS BIOLOGY	2021-12-09	—	—	US	disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

Patent	Title	Text reads most about	Predicted target · text-rank
US-20210380640-A1	SARS-CoV-2 EPITOPE-TARGETED PEPTIDE IMMUNOSTIMULANTS	ACE2, CD14, ICOSLG	GLP1R 1211/4885PLG 1803/4885PRSS1 746/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.